Manuel Gallén

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

Clara Montagut, Alba Dalmases, Beatríz Bellosillo et al. · Nature Medicine · 2012 · 506 citations

Medicine, Oncology, Pharmacology +16

Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging–Defined, Locally Advanced Rectal Cancer: Grupo Cáncer de Recto 3 Study

Carlos Fernández-Martos, Carles Pericay, Jorge Aparicio et al. · Journal of Clinical Oncology · 2010 · 434 citations · Full text

Medicine, Oncology, Surgery +16

Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites

Montserrat Andreu, Ricard Solà, Antonio Sitges‐Serra et al. · Gastroenterology · 1993 · 279 citations

Medicine, Clinical Sciences, Internal Medicine +10

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study

Eduardo Díaz‐Rubio, Auxiliadora Gómez‐España, Bartomeu Massutí et al. · The Oncologist · 2012 · 212 citations · Full text

Medicine, Oncology, Pharmacology +12

Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.

Miquel Porta, Manuel Gallén, Núria Malats et al. · Journal of Epidemiology & Community Health · 1991 · 107 citations · Full text

Medicine, Biostatistics, Oncology +17